logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10923216 B1

PDFFull Text
Date of Patent:
Feb. 16, 2021

Filed:

Jun. 12, 2020

Health status system, platform, and method

Applicant:

Tensorx, Inc., Vienna, VA (US);

Inventors:

N. Edward White, Austin, TX (US);

G. Edward Powell, Nashville, TN (US);

Van L. Marshall, Jackson, MI (US);

Mark T. Lane, Franklin, TN (US);

John C. Clerici, Vienna, VA (US);

Assignee:

TensorX, Inc., Nashville, TN (US);

Attorney:

John K. Harrop

Primary Examiner:

Linglan E Edwards

Int. Cl.
CPC ...
G16H 10/40 (2018.01); G16H 10/60 (2018.01); G16H 50/20 (2018.01); G16H 50/50 (2018.01); G07C 9/37 (2020.01); G07C 9/38 (2020.01); H04L 29/06 (2006.01); H04L 9/32 (2006.01); G06F 16/23 (2019.01); A61B 5/1172 (2016.01); A61B 5/1171 (2016.01); A61B 5/00 (2006.01); G16H 50/30 (2018.01); G06K 9/00 (2006.01); G16H 50/80 (2018.01); G06Q 50/26 (2012.01);
U.S. Cl.
CPC ...
G16H 10/40 (2018.01); A61B 5/1171 (2016.02); A61B 5/1172 (2013.01); A61B 5/4842 (2013.01); G06F 16/2365 (2019.01); G07C 9/37 (2020.01); G07C 9/38 (2020.01); G16H 10/60 (2018.01); G16H 50/20 (2018.01); G16H 50/30 (2018.01); G16H 50/50 (2018.01); H04L 9/3268 (2013.01); H04L 63/0428 (2013.01); G06K 9/00711 (2013.01); G06Q 50/265 (2013.01); G16H 50/80 (2018.01); H04L 2209/38 (2013.01);
Abstract

A health status platform includes a receiving component that receives a test result a test of a biological sample collected from a human patient. The test result includes an indication of a presence of an infectious disease in the patient, and an identification and a verification of the patient. The platform includes a certificate component that issues a certificate of origin of the biological sample; and a data merging component that cooperates with a venue access manager that controls access to a venue. The data merging component implements a distributed ledger system that stores encrypted test results of the patient and the identification and verification of the patient, and an end-to-end encryption system that receives an encrypted venue access request from a venue access manager, decrypts the access request, determines if an access request is valid, and if valid, provides an encrypted certificate of origin to the venue access manager.

Find Patent Forward Citations

Loading…